SBFMWSunshine Biopharma Inc.vs its industry peers
A metric-by-metric comparison of Sunshine Biopharma Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBFMWThis | $124463#8 | 0.0x#7 | 0.0x#6 | 0.0x#1 | 4.1%#4 | -16.4%#10 | -17.2%#1 | -21.7%#2 | -63.1%#1 | — | -86.6%#3 | — |
| NXTS | $857466#2 | 0.0x#8 | 0.5x#12 | 4.1x#6 | -20.2%#5 | 22.9%#6 | -2014.3%#5 | -210.2%#11 | — | 4#2 | — | — |
| LNAI | $756678#3 | — | — | 14.6x#8 | — | 98.0%#2 | -16729.4%#6 | — | — | — | — | — |
| DCOY | $707600#4 | 0.0x#9 | 0.2x#11 | — | -100.0%#7 | 124.4%#1 | — | 289.8%#1 | — | — | — | — |
| LABT | $477492#5 | — | 0.1x#10 | — | — | 20.8%#7 | — | -88.8%#6 | — | — | — | — |
| CDT | $51842#10 | 0.0x#3 | 0.0x#2 | — | — | -120.3%#12 | — | -38.0%#3 | — | — | — | — |
| BFRIW | $386161#6 | — | 0.1x#8 | 0.0x#2 | 11.7%#3 | 40.7%#5 | -27.2%#2 | -176.9%#9 | -712.4%#3 | — | — | — |
| SXTPW | $216295#7 | — | 0.1x#9 | 0.2x#4 | 65.5%#2 | 7.3%#8 | -771.6%#3 | -281.7%#12 | -163.8%#2 | 6#1 | 9.2%#1 | — |
| CINGW | $79980#9 | — | 0.0x#5 | — | — | -35.6%#11 | — | -95.7%#7 | — | — | — | — |
| CDTTW | $5271#15 | 0.0x#2 | 0.0x#1 | — | — | -120.3%#12 | — | -38.0%#3 | — | — | — | — |
| ERNAW | $41300#11 | 0.0x#6 | 0.0x#7 | 0.1x#3 | 755.9%#1 | 68.4%#3 | -1601.2%#4 | -440.1%#13 | -1016.2%#4 | — | — | — |
| ASBPW | $32259#12 | 0.0x#4 | 0.0x#4 | 5.2x#7 | — | -1768.9%#14 | -312016.9%#7 | -208.2%#10 | — | — | — | — |
| REVBW | $25892#13 | 0.0x#5 | 0.0x#3 | — | — | 40.7%#4 | — | -88.5%#5 | — | — | -35.6%#2 | — |
| ADTX | $7588#14 | 0.0x#1 | — | 2.4x#5 | -97.6%#6 | -6.8%#9 | -612542.2%#8 | — | — | — | — | — |
| AAPG | $5.9B#1 | — | 164.2x#13 | 47.8x#9 | — | — | — | -153.5%#8 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice